Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Leukemia, Promyelocytic, Acute × Arsenic Trioxide × Clear all

Phase

Status

Sponsor Class

OTHER 18 INDUSTRY 3 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Promyelocytic, Acute 1 Leukemia 1 Childhood Acute Promyelocytic Leukemia With PML-RARA 1

Interventions

Gemtuzumab 2 Flow Cytometry 2 sargramostim 1 Tretinoin 1 Topotecan 1 Microscopy 1 Methotrexate 1 Mercaptopurine 1 Daunorubicin 1 Cytarabine 1 Cyclophosphamide 1 Blotting, Western 1 Arsenic Trioxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00551460 2023-01-10

S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

SWOG Cancer Research Network

Phase 2 Completed

78 enrolled 8 charts

Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡